Clinical Trial Update: LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema) [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study evaluating the probiotic Lactobacillus paracasei LPB27 (LaCE) for early childhood eczema. The study, sponsored by The U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LaCE LPB27 (Lactobacillus paracasei LPB27)

Snippet

Sponsor: The University of New South Wales | Conditions: Eczema, Allergy | Phase 2 | Status: RECRUITING